Who should NOT use MOTs-C
A single-nutrient injection designed to boost energy levels, support metabolism and combat fatigue by enhancing red blood cell production and cellular energy
It is critical to not self-diagnose a B12 deficiency or self-administer injections
transitory exanthema Miscellaneous: Feeling of swelling of entire body Drug Interactions for Cyanocobalamin Persons taking most antibiotics, methotrexate and pyrimethamine invalidate folic acid and vitamin B 12 diagnostic blood assays
Phase III results for retatrutide are set to be released later in 2025 and in early 2026, but an earlier phase II trial recorded between a 7.2% and 17.5% reduction in body weight after 24 weeks, depending on the dose (7.2% on 1mg, 17.5% on 12mg), and up to a 24.2% reduction in body weight after 48 weeks for those on 12mg (-8.7% change for those on 1mg) 8
Yes, in research settings, these two are sometimes studied together